Type-2-low severe asthma endotypes for new treatments: the new asthma frontier
{{output}}
Purpose of review: Type-2 (T2)-high asthma represents a well defined group of severe eosinophilic asthma for which there are now effective biologic therapies targetting the interleukins (ILs) 4, 5 and 13, and Immunoglobulin E. T2... ...
